Skip to main content
. Author manuscript; available in PMC: 2018 May 14.
Published in final edited form as: Pediatr Infect Dis J. 2018 May;37(5):383–386. doi: 10.1097/INF.0000000000001783

Figure 2.

Figure 2

Estimated survival curves of time to first diagnosis of asthma by LAIV and placebo groups, Kaiser Permanente Northern California, 2001–2014

Note: Asthma-free survival among LAIV recipients is shown by the dark blue line, with surrounding 95% confidence interval in light blue. Asthma-free survival among placebo recipients is shown by the red line, with surrounding 95% confidence interval in light red. The substantial overlap of 95% confidence intervals is purple in color.